Grace Therapeutics, Inc.Grace Therapeutics, Inc.Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

No trades
See on Supercharts

Price target

10.830.000.00%
The 3 analysts offering 1 year price forecasts for GRCE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to GRCE in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


GRCE EPS for the last quarter is −0.30 USD despite the estimation of −0.37 USD. In the next quarter EPS is expected to reach −0.32 USD. Track more of Grace Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Grace Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Grace Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, GRCE price target is 10.83 USD with a max estimate of 12.50 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Grace Therapeutics, Inc. stock price chart and keep track of the current situation with GRCE news and stock market news.